Cipla launches Yurpeak for treatment of obesity, Type 2 diabetes

Dec 10, 2025

Cipla Limited on Wednesday announced the launch of Yurpeak (tirzepatide), a once-weekly injectable therapy for the management of obesity and type 2 diabetes mellitus...